Management of Stage III Non Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Navneet Singh, Megan E. Daly, Nofisat Ismaila, Megan E. Daly, Navneet Singh, Mara B. Antonoff, Douglas A. Arenberg, Jeffrey Bradley, Elizabeth David, Frank Detterbeck, Martin Früh, Matthew A. Gubens, Amy C. Moore, Sukhmani K. Padda, Jyoti D. Patel, Tanyanika Phillips, Angel Qin, Clifford Robinson

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).

Original languageEnglish (US)
Pages (from-to)4430-4432
Number of pages3
JournalJournal of Clinical Oncology
Volume41
Issue number27
DOIs
StatePublished - Sep 20 2023

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Management of Stage III Non Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update'. Together they form a unique fingerprint.

Cite this